“Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos

Claudia Boyd-Barrett and Renuka Rayasam and Amanda Seitz / kffhealthnews - Se supone que la agencia que cuida a niños que llegan solos al país deben reunirlos pronto con sus familias o cuidadores. Pero cada vez más los usan como “carnada” para arrestar a los padres.

AI Summary: Gilead struck a deal to acquire Ouro Medicines for roughly $1.68–1.7 billion, securing an immune‑modulating autoimmune program intended to reset pathological immune responses. The transaction combines upfront cash and potential milestones, expanding Gilead’s pipeline and signaling continued industry appetite for bolt‑on buys to chase novel therapeutics.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Biogen announces $5.6B acquisition of Apellis Pharma / 1 month

Novartis closes Avidity deal; Atrium Therapeutics spinout launches / 2 months

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio / 2 months

Chiesi acquires KalVista for $1.9B to bolster rare disease pipeline / 29 days

Gilead acquires Tubulis in multibillion-dollar push beyond HIV / 7 wks

Eli Lilly buys Centessa for $6.3B to enter sleep disorder market / 2 months

Servier to acquire Day One Biopharma for $2.5B / 2 months